Menicon Co (7780) AI Stock Analysis

• Market Cap: ¥130.55B
• Dividend Yield: 1.78%
• Average Volume (3M): 317.29K
• Price to Earnings (P/E): 9.3
• Beta (1Y): 0.66
• Revenue Growth: 3.17%
• EPS Growth: 7.07%
• Country: JP
• Employees: 4,221
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 42.86
• Shares Outstanding: 76,761,890
• 10 Day Avg. Volume: 331,470
• 30 Day Avg. Volume: 317,293
• PEG Ratio: 0.70
• Price to Book (P/B): 1.10
• Price to Sales (P/S): 0.78
• P/FCF Ratio: -1.23K
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,283.33
• Price Target Upside: 42.98% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): 95.55
• Revenue Forecast (FY): ¥130.82B

• Rating: 74 Outperform
• Price Target: ¥1,922.00 ▲(20.35% Upside)
• Action: Reiterated Date: 11/30/25
• Date: Action: Reiterated 11/30/25

Menicon Co's strong financial performance and bullish technical indicators are the primary drivers of its stock score. Despite a high P/E ratio suggesting overvaluation, the company's robust revenue growth and profitability, along with strong market momentum, support a favorable outlook. However, investors should be cautious of potential pullbacks due to overbought conditions and monitor the company's debt levels and cash flow management.

Positive Factors

Revenue Growth Consistency

Consistent year-over-year revenue growth shows sustained demand for Menicon's contact lenses and consumables. This supports stable top-line momentum, predictable cash inflows for reinvestment in R&D and distribution, and underpins medium-term business visibility across 2–6 months.

Negative Factors

Negative Free Cash Flow due to CapEx

Persistent negative free cash flow driven by high capital spending reduces financial flexibility and limits capacity for shareholder returns or debt reduction. If capex remains elevated, the company may need to prioritize investment over distributions or rely on external funding in the medium term.

Menicon Co Business Overview & Revenue Model

Company Description

Menicon Co., Ltd. manufactures and sells contact lenses and lens care products. The company offers its products to hospitals, ophthalmology clinics, contact lens stores, eyeglass stores, and drug stores. It exports its products in 80 countries, in...

Read more

Menicon Co., Ltd. manufactures and sells contact lenses and lens care products. The company offers its products to hospitals, ophthalmology clinics, contact lens stores, eyeglass stores, and drug stores. It exports its products in 80 countries, in...

How the Company Makes Money

Menicon primarily makes money by selling contact lenses and associated eye care products. Its core revenue stream comes from the manufacture and sale of contact lenses to customers through distribution channels that can include eye-care profession...

Read more

Menicon primarily makes money by selling contact lenses and associated eye care products. Its core revenue stream comes from the manufacture and sale of contact lenses to customers through distribution channels that can include eye-care profession...

Menicon Co Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	121.59B	121.49B	116.19B	110.19B	100.17B	86.21B
Gross Profit	64.66B	65.08B	61.01B	58.48B	52.88B	45.82B
EBITDA	18.23B	18.52B	15.74B	19.33B	17.52B	14.13B
Net Income	4.85B	5.62B	4.54B	7.38B	6.48B	5.95B
Balance Sheet
Total Assets	182.63B	187.28B	179.81B	152.52B	130.98B	126.73B
Cash, Cash Equivalents and Short-Term Investments	32.29B	42.05B	46.91B	41.30B	33.05B	41.45B
Total Debt	74.14B	75.09B	70.79B	53.58B	42.44B	45.30B
Total Liabilities	97.74B	101.13B	98.01B	77.86B	63.93B	65.74B
Stockholders Equity	84.82B	86.10B	81.75B	74.61B	67.00B	60.94B
Cash Flow
Free Cash Flow	0.00	-77.00M	-8.24B	1.31B	-2.00B	437.00M
Operating Cash Flow	0.00	13.94B	11.87B	12.75B	12.72B	10.63B
Investing Cash Flow	0.00	-19.66B	-21.57B	-13.78B	-16.15B	-15.63B
Financing Cash Flow	0.00	714.00M	14.55B	8.90B	-5.40B	28.91B

Menicon Co Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1597.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7780, the sentiment is Neutral. The current price of 1597 is below the 20-day moving average (MA) of 1719.38, below the 50-day MA of 1725.21, and above the 200-day MA of 1390.86, indicating a neutral trend. The MACD of 7.70 indicates Negative momentum. The RSI at 48.52 is Neutral, neither overbought nor oversold. The STOCH value of 32.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7780.

Menicon Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7741	80 Outperform	¥9.85T	21.89	25.14%	1.01%	8.83%	8.63%
5889	78 Outperform	¥51.65B	12.81	―	3.22%	12.92%	29.48%
7780	74 Outperform	¥130.55B	9.26	7.81%	1.78%	3.17%	7.07%
7730	71 Outperform	¥153.49B	18.72	―	2.73%	5.10%	-26.13%
3046	65 Neutral	¥148.68B	16.09	27.95%	1.97%	17.13%	78.33%
7743	58 Neutral	¥17.95B	58.26	―	2.65%	0.81%	-26.76%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Menicon Co Corporate Events